Health Care and Payment Reform and Massachusetts Psychological Association Advocacy

2013 ◽  
Author(s):  
Elena J. Eisman
Keyword(s):  
2018 ◽  
Vol 172 (6) ◽  
pp. 513 ◽  
Author(s):  
Charlene A. Wong ◽  
James M. Perrin ◽  
Mark McClellan

Author(s):  
Shuang Qin Zhang ◽  
Blase N. Polite

The Patient Protection and Affordable Care Act (ACA) was signed into law by President Barack Obama on March 23, 2010. Since that time, numerous regulations have been promulgated, legal battles continue to be fought and the major provisions of the law are being implemented. In the following article, we outline components of the ACA that are relevant to cancer health care, review current implementation of the new health care reform law, and identify challenges that may lie ahead in the post-ACA era. Specifically, among the things we explore are Medicaid expansion, health insurance exchanges, essential health benefits and preventive services, subsidies, access to clinical trials, the Medicare Part D donut hole, and physician quality payment reform.


2015 ◽  
Vol 11 (3) ◽  
pp. 223-230 ◽  
Author(s):  
Mark B. McClellan ◽  
Andrea I. Thoumi

The authors describe features of quality and cost measures needed to support accountable care payment reforms in oncology and propose policy recommendations to move to payment systems that support higher-value care in oncology.


2014 ◽  
Vol 111 ◽  
pp. 10-16 ◽  
Author(s):  
Chen Gao ◽  
Fei Xu ◽  
Gordon G. Liu
Keyword(s):  

2014 ◽  
Vol 10 (sup1) ◽  
pp. S104-S119 ◽  
Author(s):  
Cheryl Cashin ◽  
Nguyen Khanh Phuong ◽  
Ryan Shain ◽  
Tran Thi Mai Oanh ◽  
Nguyen Thi Thuy

2021 ◽  
Author(s):  
Masako Ii ◽  
Sachiko Watanabe

Analyzing data from a large, nationally distributed group of Japanese hospitals, we found a dramatic decline in both inpatient and outpatient volumes over the three waves of the COVID-19 pandemic in Japan from February-December 2020. We identified three key reasons for this fall in patient demand. First, COVID-19-related hygiene measures and behavioral changes significantly reduced non-COVID-19 infectious diseases. Second, consultations relating to chronic diseases fell sharply. Third, certain medical investigations and interventions were postponed or cancelled. Despite the drop in hospital attendances and admissions, COVID-19 is said to have brought the Japanese health care system to the brink of collapse. In this context, we explore longstanding systematic issues, finding that Japan's abundant supply of beds and current payment system may have introduced a perverse incentive to overprovide services, creating a mismatch between patient needs and the supply of health care resources. Poor coordination among health care providers and the highly decentralized governance of the health care system have also contributed to the crisis. In order to ensure the long-term sustainability of the Japanese health care system beyond COVID-19, it is essential to promote specialization and differentiation of medical functions among hospitals, to strengthen governance, and to introduce appropriate payment reform.


Sign in / Sign up

Export Citation Format

Share Document